A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: The Women's Health Initiative

Marian L. Neuhouser, Barbara Howard, Jingmin Lu, Lesley F. Tinker, Linda Van Horn, Bette Caan, Thomas Rohan, Marcia L. Stefanick, Cynthia Thomson

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: Nutrition plays an important role in metabolic syndrome etiology. We examined whether the Women's Health Initiative (WHI) Dietary Modification Trial influenced metabolic syndrome risk. Materials/Methods: 48,835 postmenopausal women aged 50-79 years were randomized to a low-fat (20% energy from fat) diet (intervention) or usual diet (comparison) for a mean of 8.1 years. Blood pressure, waist circumference and fasting blood measures of glucose, HDL-cholesterol and triglycerides were measured on a subsample (n = 2816) at baseline and years 1, 3 and 6 post-randomization. Logistic regression estimated associations of the intervention with metabolic syndrome risk and use of cholesterol-lowering and hypertension medications. Multivariate linear regression tested associations between the intervention and metabolic syndrome components. Results: At year 3, but not years 1 or 6, women in the intervention group (vs. comparison) had a non-statistically significant lower risk of metabolic syndrome (OR = 0.83, 95%CI 0.59-1.18). Linear regression models simultaneously modeling the five metabolic syndrome components revealed significant associations of the intervention with metabolic syndrome at year 1 (p < 0.0001), but not years 3 (p = 0.19) and 6 (p = 0.17). Analyses restricted to intervention-adherent participants strengthened associations at years 3 (p = 0.05) and 6 (p = 0.06). Cholesterol-lowering and hypertension medication use was 19% lower at year 1 for intervention vs. comparison group women (OR = 0.81, 95% CI 0.60-1.09).Over the entire trial, fewer intervention vs. comparison participants used these medications (26.0% vs. 29.9%), although results were not statistically significant (p = 0.89). Conclusions: The WHI low-fat diet may influence metabolic syndrome risk and decrease use of hypertension and cholesterol-lowering medications. Findings have potential for meaningful clinical translation.

Original languageEnglish (US)
Pages (from-to)1572-1581
Number of pages10
JournalMetabolism: Clinical and Experimental
Volume61
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint

Dietary Fats
Women's Health
Linear Models
Cholesterol
Hypertension
Fats
Diet
Diet Therapy
Fat-Restricted Diet
Waist Circumference
Random Allocation
HDL Cholesterol
Blood Glucose
Fasting
Triglycerides
Logistic Models
Blood Pressure

Keywords

  • Aging
  • Clinical trials
  • Dietary fat
  • Metabolic syndrome

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women : The Women's Health Initiative. / Neuhouser, Marian L.; Howard, Barbara; Lu, Jingmin; Tinker, Lesley F.; Van Horn, Linda; Caan, Bette; Rohan, Thomas; Stefanick, Marcia L.; Thomson, Cynthia.

In: Metabolism: Clinical and Experimental, Vol. 61, No. 11, 11.2012, p. 1572-1581.

Research output: Contribution to journalArticle

Neuhouser, Marian L. ; Howard, Barbara ; Lu, Jingmin ; Tinker, Lesley F. ; Van Horn, Linda ; Caan, Bette ; Rohan, Thomas ; Stefanick, Marcia L. ; Thomson, Cynthia. / A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women : The Women's Health Initiative. In: Metabolism: Clinical and Experimental. 2012 ; Vol. 61, No. 11. pp. 1572-1581.
@article{d4dacb7b26024f259d69b646fb82133f,
title = "A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: The Women's Health Initiative",
abstract = "Objective: Nutrition plays an important role in metabolic syndrome etiology. We examined whether the Women's Health Initiative (WHI) Dietary Modification Trial influenced metabolic syndrome risk. Materials/Methods: 48,835 postmenopausal women aged 50-79 years were randomized to a low-fat (20{\%} energy from fat) diet (intervention) or usual diet (comparison) for a mean of 8.1 years. Blood pressure, waist circumference and fasting blood measures of glucose, HDL-cholesterol and triglycerides were measured on a subsample (n = 2816) at baseline and years 1, 3 and 6 post-randomization. Logistic regression estimated associations of the intervention with metabolic syndrome risk and use of cholesterol-lowering and hypertension medications. Multivariate linear regression tested associations between the intervention and metabolic syndrome components. Results: At year 3, but not years 1 or 6, women in the intervention group (vs. comparison) had a non-statistically significant lower risk of metabolic syndrome (OR = 0.83, 95{\%}CI 0.59-1.18). Linear regression models simultaneously modeling the five metabolic syndrome components revealed significant associations of the intervention with metabolic syndrome at year 1 (p < 0.0001), but not years 3 (p = 0.19) and 6 (p = 0.17). Analyses restricted to intervention-adherent participants strengthened associations at years 3 (p = 0.05) and 6 (p = 0.06). Cholesterol-lowering and hypertension medication use was 19{\%} lower at year 1 for intervention vs. comparison group women (OR = 0.81, 95{\%} CI 0.60-1.09).Over the entire trial, fewer intervention vs. comparison participants used these medications (26.0{\%} vs. 29.9{\%}), although results were not statistically significant (p = 0.89). Conclusions: The WHI low-fat diet may influence metabolic syndrome risk and decrease use of hypertension and cholesterol-lowering medications. Findings have potential for meaningful clinical translation.",
keywords = "Aging, Clinical trials, Dietary fat, Metabolic syndrome",
author = "Neuhouser, {Marian L.} and Barbara Howard and Jingmin Lu and Tinker, {Lesley F.} and {Van Horn}, Linda and Bette Caan and Thomas Rohan and Stefanick, {Marcia L.} and Cynthia Thomson",
year = "2012",
month = "11",
doi = "10.1016/j.metabol.2012.04.007",
language = "English (US)",
volume = "61",
pages = "1572--1581",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women

T2 - The Women's Health Initiative

AU - Neuhouser, Marian L.

AU - Howard, Barbara

AU - Lu, Jingmin

AU - Tinker, Lesley F.

AU - Van Horn, Linda

AU - Caan, Bette

AU - Rohan, Thomas

AU - Stefanick, Marcia L.

AU - Thomson, Cynthia

PY - 2012/11

Y1 - 2012/11

N2 - Objective: Nutrition plays an important role in metabolic syndrome etiology. We examined whether the Women's Health Initiative (WHI) Dietary Modification Trial influenced metabolic syndrome risk. Materials/Methods: 48,835 postmenopausal women aged 50-79 years were randomized to a low-fat (20% energy from fat) diet (intervention) or usual diet (comparison) for a mean of 8.1 years. Blood pressure, waist circumference and fasting blood measures of glucose, HDL-cholesterol and triglycerides were measured on a subsample (n = 2816) at baseline and years 1, 3 and 6 post-randomization. Logistic regression estimated associations of the intervention with metabolic syndrome risk and use of cholesterol-lowering and hypertension medications. Multivariate linear regression tested associations between the intervention and metabolic syndrome components. Results: At year 3, but not years 1 or 6, women in the intervention group (vs. comparison) had a non-statistically significant lower risk of metabolic syndrome (OR = 0.83, 95%CI 0.59-1.18). Linear regression models simultaneously modeling the five metabolic syndrome components revealed significant associations of the intervention with metabolic syndrome at year 1 (p < 0.0001), but not years 3 (p = 0.19) and 6 (p = 0.17). Analyses restricted to intervention-adherent participants strengthened associations at years 3 (p = 0.05) and 6 (p = 0.06). Cholesterol-lowering and hypertension medication use was 19% lower at year 1 for intervention vs. comparison group women (OR = 0.81, 95% CI 0.60-1.09).Over the entire trial, fewer intervention vs. comparison participants used these medications (26.0% vs. 29.9%), although results were not statistically significant (p = 0.89). Conclusions: The WHI low-fat diet may influence metabolic syndrome risk and decrease use of hypertension and cholesterol-lowering medications. Findings have potential for meaningful clinical translation.

AB - Objective: Nutrition plays an important role in metabolic syndrome etiology. We examined whether the Women's Health Initiative (WHI) Dietary Modification Trial influenced metabolic syndrome risk. Materials/Methods: 48,835 postmenopausal women aged 50-79 years were randomized to a low-fat (20% energy from fat) diet (intervention) or usual diet (comparison) for a mean of 8.1 years. Blood pressure, waist circumference and fasting blood measures of glucose, HDL-cholesterol and triglycerides were measured on a subsample (n = 2816) at baseline and years 1, 3 and 6 post-randomization. Logistic regression estimated associations of the intervention with metabolic syndrome risk and use of cholesterol-lowering and hypertension medications. Multivariate linear regression tested associations between the intervention and metabolic syndrome components. Results: At year 3, but not years 1 or 6, women in the intervention group (vs. comparison) had a non-statistically significant lower risk of metabolic syndrome (OR = 0.83, 95%CI 0.59-1.18). Linear regression models simultaneously modeling the five metabolic syndrome components revealed significant associations of the intervention with metabolic syndrome at year 1 (p < 0.0001), but not years 3 (p = 0.19) and 6 (p = 0.17). Analyses restricted to intervention-adherent participants strengthened associations at years 3 (p = 0.05) and 6 (p = 0.06). Cholesterol-lowering and hypertension medication use was 19% lower at year 1 for intervention vs. comparison group women (OR = 0.81, 95% CI 0.60-1.09).Over the entire trial, fewer intervention vs. comparison participants used these medications (26.0% vs. 29.9%), although results were not statistically significant (p = 0.89). Conclusions: The WHI low-fat diet may influence metabolic syndrome risk and decrease use of hypertension and cholesterol-lowering medications. Findings have potential for meaningful clinical translation.

KW - Aging

KW - Clinical trials

KW - Dietary fat

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=84867853224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867853224&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2012.04.007

DO - 10.1016/j.metabol.2012.04.007

M3 - Article

C2 - 22633601

AN - SCOPUS:84867853224

VL - 61

SP - 1572

EP - 1581

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 11

ER -